Cargando…

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab

Detalles Bibliográficos
Autores principales:	Galeotti, C, Boucheron, A, Guillaume, S, Koné-Paut, I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194719/ http://dx.doi.org/10.1186/1546-0096-9-S1-P6

Ejemplares similares

PReS-FINAL-2198: Insufficient efficacy of tocilizumab therapy in children with Castleman's disease
por: Kozlova, A, et al.
Publicado: (2013)

Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease
por: Vargas, Ana Beatriz, et al.
Publicado: (2012)

Idiopathic multicentric Castleman disease preceded by cutaneous plasmacytosis successfully treated by tocilizumab
por: Aita, Tetsuro, et al.
Publicado: (2020)

PReS-FINAL-2208: Sacroilitis with propionibacterium acnes in a child
por: Galeotti, C, et al.
Publicado: (2013)

Multicentric Castleman's Disease (CD) in juvenile idiopathic arthritis (JIA) treated with etanercept: coincidence or causal relationship?
por: Rossi, L, et al.
Publicado: (2008)

Survey of off-label anti-IL1 treatments in France: preliminary data
por: Rossi-Semerano, L, et al.
Publicado: (2011)

Interleukin-1 antagonists in Mevalonate Kinase Deficiency
por: Galeotti, C, et al.
Publicado: (2011)

Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report
por: Han, Ping-Yang, et al.
Publicado: (2020)

Psoas and Mediastinal Abscesses during Intravenous Tocilizumab Treatment in Multicentric Castleman Disease
por: Togitani, Kazuto, et al.
Publicado: (2022)

Refractory Uveitis in Patient with Castleman Disease Successfully Treated with Tocilizumab
por: Oshitari, Toshiyuki, et al.
Publicado: (2012)

Resrip: a network dedicated to children and adolescents suffering from chronic rheumatic diseases in the Ile-de-France region
por: Rossi-Semerano, Linda, et al.
Publicado: (2014)

Membranous nephropathy associated with multicentric Castleman’s disease that was successfully treated with tocilizumab: a case report and review of the literature
por: Saiki, Ryosuke, et al.
Publicado: (2021)

Multicentric Castleman’s disease in HIV/AIDS patients at an urban HIV clinic in Atlanta, Georgia, in the combined antiretroviral therapy era
por: Pillai, Rathi N, et al.
Publicado: (2012)

Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report
por: Cai, Sisi, et al.
Publicado: (2019)

The clinical spectrum of 94 French patients carrying a single mutated MEFV allele
por: Koné-Paut, I, et al.
Publicado: (2008)

Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease
por: Arakawa, Akira, et al.
Publicado: (2021)

Familial Mediterranean Fever (FMF) before the age of one year
por: Delion, F, et al.
Publicado: (2008)

Erdheim-Chester disease in children: clinical, radiologic, treatment characteristics of three cases
por: Eyssette-Guerreau, S, et al.
Publicado: (2008)

Idiopathic Multicentric Castleman Disease with Autoimmune Hemolytic Anemia and Production of Anti-drug Antibody against Tocilizumab
por: Tabata, Sakiko, et al.
Publicado: (2019)

Role of CD4(+)CD25(hi)CD127(lo/-)FoxP3(+) regulatory T lymphocytes in the pathogenesis of Behçet’s disease in children
por: Tran, TA, et al.
Publicado: (2011)

Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
por: Horneff, G, et al.
Publicado: (2015)

A Case of Multicentric Castleman's Disease Having Lung Lesion Successfully Treated with Humanized Anti-interleukin-6 Receptor Antibody, Tocilizumab
por: Higuchi, Tomoaki, et al.
Publicado: (2010)

PReS-FINAL-2228: Survey of off-label ANTI-IL1 treatments in France: two years data
por: Rossi-Semerano, L, et al.
Publicado: (2013)

Rationale and efficacy of interleukin-1 targeting in pediatric Erdheim- Chester disease
por: Tran, TA, et al.
Publicado: (2011)

The French paediatric cohort of Castleman disease: a retrospective report of 23 patients
por: Borocco, Charlotte, et al.
Publicado: (2020)

[(18)F]-fluoro-D-deoxyglucose positron emission tomography findings in Kaposi sarcoma herpes virus associated multicentric Castleman disease: correlation with clinical, inflammatory, and virologic parameters
por: Polizzotto, Mark N, et al.
Publicado: (2012)

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
por: De Benedetti, Fabrizio, et al.
Publicado: (2014)

The use of colchicine in PFAPA syndrome, the french experience and literature review
por: Dusser, Perrine, et al.
Publicado: (2014)

Successful treatment with tocilizumab for refractory anemia and slowly progressive renal glomerulosclerosis in multicentric Castleman disease: A case report
por: Sugawara, Eri, et al.
Publicado: (2022)

P1140: TIME TO TUMOR, SYMPTOMATIC AND LABORATORY RESPONSES FOLLOWING SILTUXIMAB TREATMENT IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE
por: van Rhee, F., et al.
Publicado: (2022)

HIV-associated multicentric Castleman's disease
por: Naime, Fauzia de Fátima, et al.
Publicado: (2012)

Multicentric Castleman disease and the evolution of the concept
por: Zhou, Ting, et al.
Publicado: (2021)

Hypofertility in Muckle Wells syndrome and treatment with IL-1 targeting drugs
por: Meinzer, Ulrich, et al.
Publicado: (2011)

PReS-FINAL-2167: What is the potential of intra-articular corticosteroid injections to induce sustained remission in children with juvenile idiopathic arthritis?
por: Lanni, S, et al.
Publicado: (2013)

PReS-FINAL-2103: Real life management of VZV infection or reactivation in rheumatic children on biologics: the French experience
por: Guillaume-Czitrom, S, et al.
Publicado: (2013)

Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
por: Alexeeva, E, et al.
Publicado: (2011)

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
por: Nemiche, O, et al.
Publicado: (2011)

“Daily life of CAPS patients treated with canakinumab (Ilaris(®)) : data from the French observational study - ENVOL Study”
por: Koné-Paut, I, et al.
Publicado: (2015)

Effects of antirheumatic treatment with tocilizumab on longitudinal growth in children with juvenile idiopathic arthritis
por: Alexeeva, Ekaterina, et al.
Publicado: (2014)

Tocilizumab-effective multicentric Castleman's disease with infiltration of eosinophil and IgG(4)-positive plasma cells: A case report
por: Katsumata, Yusuke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_inrkd1nnk1fo568iom5bltm4p4